Each dot is one of the 219 Healthcare stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 10.1% and the median P/E 23.02. Pinned to the edge: 16 outliers on X and 9 on Y.
Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.
| # | Industry | ||||
|---|---|---|---|---|---|
| 1 | LLYEli Lilly | 45.5% | 46.74 | $1.36T | Pharmaceuticals |
| 2 | JNJJohnson & Johnson | 7.8% | 42.83 | $688.76B | Pharmaceuticals |
| 3 | ABBVAbbVie | 10.7% | 50.48 | $521.69B | Pharmaceuticals |
| 4 | UNHUnitedhealth | 3.3% | 23.02 | $365.22B | Managed Care |
| 5 | MRKMerck | 4.9% | 148.68OUT | $364.31B | Pharmaceuticals |
| 6 | AZNAstrazeneca | 7.8% | 25.92 | $285.96B | Pharmaceuticals |
| 7 | TMOThermo Fisher Scientific | 8.3% | 36.63 | $259.44B | Life Sciences Tools |
| 8 | AMGNAmgen | 8.2% | 26.83 | $251.88B | Biotechnology |
| 9 | ABTAbbott Laboratories | 10.0% | 40.05 | $187.98B | Medical Devices |
| 10 | PFEPfizer | 1.3% | 40.85 | $164.73B | Pharmaceuticals |
| 11 | DHRDanaher | 5.5% | 37.87 | $163.91B | Life Sciences Tools |
| 12 | ISRGIntuitive Surgical | 20.5% | 52.35 | $153.75B | Medical Devices |
| 13 | VRTXVertex Pharmaceuticals | 10.5% | 34.34 | $136.55B | Biotechnology |
| 14 | MDTMedtronic | 12.8% | 15.04 | $131.67B | Medical Devices |
| 15 | BMYBristol Myers Squibb | 4.2% | 14.02 | $129.66B | Pharmaceuticals |
| 16 | MCKMckesson | 8.2% | 27.29 | $127.33B | Drug Distribution |
| 17 | SYKStryker | 7.9% | 32.65 | $117.84B | Medical Devices |
| 18 | CVSCvs Health | 6.7% | 10.38 | $114.34B | Managed Care |
| 19 | GSKGsk | 82.9% | 8.11 | $108.86B | Pharmaceuticals |
| 20 | HCAHCA Healthcare | 5.8% | 15.81 | $105.29B | Hospitals |
| 21 | REGNRegeneron Pharmaceuticals | 18.6% | 20.17 | $97.17B | Biotechnology |
| 22 | ELVElevance Health | 3.6% | 18.11 | $92.86B | Managed Care |
| 23 | CICigna | 6.8% | 13.03 | $78.25B | Managed Care |
| 24 | CORCencora | 5.0% | 22.64 | $68.51B | Drug Distribution |
| 25 | CAHCardinal Health | 10.0% | 35.87 | $64.97B | Drug Distribution |
| 26 | BSXBoston Scientific | 8.9% | 18.34 | $64.27B | Medical Devices |
| 27 | EWEdwards Lifesciences | 13.4% | 60.87 | $61.69B | Medical Devices |
| 28 | ARGXArgenx Se | 61.5% | 31.35 | $59.41B | Biotechnology |
| 29 | SNYSanofi | -19.6% | 6.24 | $58.98B | Pharmaceuticals |
| 30 | IDXXIdexx Laboratories | 11.9% | 46.96 | $55.49B | Animal Health |
| 31 | HUMHumana | 22.0% | 43.42 | $54.10B | Managed Care |
| 32 | TEVATeva Pharmaceutical Industries | 2.7% | 102.64 | $51.97B | Generic Drugs |
| 33 | AAgilent Technologies | 8.6% | 34.06 | $49.04B | Life Sciences Tools |
| 34 | ONCBeOne Medicines | 32.9% | 51.73 | $47.53B | Pharmaceuticals |
| 35 | IQVIqvia Holdings | 8.8% | 31.30 | $43.67B | Contract Research |
| 36 | GEHCGE HealthCare Technologies | 6.9% | 17.42 | $37.54B | Diagnostic Equipment |
| 37 | BIIBBiogen | 2.3% | 107.78 | $37.46B | Biotechnology |
| 38 | ALCAlcon | 8.0% | 54.90 | $36.13B | Medical Devices |
| 39 | ZTSZoetis | 0.9% | 13.76 | $34.16B | Animal Health |
| 40 | RMDResmed | 9.0% | 21.50 | $33.69B | Medical Devices |
| 41 | ILMNIllumina | 5.8% | 34.93 | $31.30B | Life Sciences Tools |
| 42 | DXCMDexcom | 13.0% | 31.51 | $31.08B | Medical Devices |
| 43 | LHLabcorp Holdings | 6.0% | 29.94 | $30.09B | Diagnostic Labs |
| 44 | PHGKoninklijke Philips | 53.4% | 15.11 | $29.22B | Diagnostic Equipment |
| 45 | WSTWest Pharmaceutical Services | 12.6% | 45.92 | $29.09B | Medical Supplies |
| 46 | DGXQuest Diagnostics | 9.1% | 25.31 | $28.58B | Diagnostic Labs |
| 47 | STESteris | 8.1% | 31.11 | $25.67B | Medical Devices |
| 48 | UTHRUnited Therapeutics | 1.9% | 20.51 | $25.06B | Pharmaceuticals |
| 49 | ALNYAlnylam Pharmaceuticals | 60.8% | 8.34 | $22.09B | Biotechnology |
| 50 | ZBHZimmer Biomet Holdings | 7.0% | 25.63 | $19.53B | Medical Devices |
| 51 | MEDPMedpace Holdings | 20.4% | 35.28 | $18.29B | Contract Research |
| 52 | RVTYRevvity | 4.6% | 68.10 | $17.25B | Life Sciences Tools |
| 53 | ASNDAscendis Pharma A | 93.8%OUT | 16.31 | $17.07B | Biotechnology |
| 54 | NBIXNeurocrine Biosciences | 38.0% | 24.21 | $16.96B | Pharmaceuticals |
| 55 | EXELExelixis | 9.1% | 19.24 | $16.88B | Pharmaceuticals |
| 56 | CRLCharles River Laboratories International | -1.2% | 402.10OUT | $16.18B | Contract Research |
| 57 | SOLVSolventum | -2.8% | 97.50 | $15.13B | Medical Devices |
| 58 | KNSAKiniksa Pharmaceuticals International | 58.2% | 68.75 | $15.13B | Biotechnology |
| 59 | ICLRIcon | 1.8% | 34.02 | $14.90B | Contract Research |
| 60 | BTSGBrightSpring Health Services | 26.0% | 35.93 | $14.16B | Home Health and Senior Care |
| 61 | EHCEncompass Health | 9.4% | 21.50 | $13.83B | Hospitals |
| 62 | PENPenumbra | 17.0% | 80.51 | $12.65B | Medical Devices |
| 63 | RDYDr Reddys Laboratories | -10.5% | 33.78 | $12.31B | Generic Drugs |
| 64 | COOCooper Companies | 4.7% | 21.20 | $11.91B | Medical Devices |
| 65 | ALGNAlign Technology | 4.4% | 24.29 | $11.90B | Dental |
| 66 | TECHBio-Techne | 0.9% | 66.38 | $11.43B | Life Sciences Tools |
| 67 | HALOHalozyme Therapeutics | 45.0% | 23.51 | $11.42B | Biotechnology |
| 68 | DVADavita | 6.4% | 12.11 | $11.06B | Healthcare Services |
| 69 | ENSGEnsign | 17.5% | 27.30 | $10.99B | Home Health and Senior Care |
| 70 | QGENQiagen | 2.2% | 28.16 | $10.82B | Life Sciences Tools |
| 71 | PODDInsulet | 26.5% | 24.66 | $10.58B | Medical Devices |
| 72 | BIOBio-Rad Laboratories | 1.4% | 9.59 | $9.85B | Life Sciences Tools |
| 73 | UHSUniversal Health Services | 8.0% | 7.82 | $9.80B | Hospitals |
| 74 | TGTXTg Therapeutics | 68.8% | 85.63 | $9.75B | Biotechnology |
| 75 | GMEDGlobus Medical | 13.4% | 17.35 | $9.56B | Medical Devices |
| 76 | HSICHenry Schein | 6.2% | 22.79 | $9.53B | Drug Distribution |
| 77 | HNGEHinge Health | 49.9% | 56.01 | $9.37B | Telehealth |
| 78 | KRYSKrystal Biotech | 26.0% | 40.14 | $9.04B | Gene and Cell Therapy |
| 79 | OSCROscar Health | 54.8% | 11.23 | $8.56B | Managed Care |
| 80 | PTGXProtagonist Therapeutics | 163.7%OUT | 25.39 | $8.54B | Biotechnology |
| 81 | CORTCorcept Therapeutics | 30.0% | 48.81 | $7.98B | Pharmaceuticals |
| 82 | PACSPacs | 11.0% | 27.59 | $7.67B | Home Health and Senior Care |
| 83 | AMRXAmneal Pharmaceuticals | 8.9% | 53.85 | $7.45B | Generic Drugs |
| 84 | CHEChemed | 5.2% | 25.36 | $7.14B | Home Health and Senior Care |
| 85 | LNTHLantheus Holdings | 2.4% | 24.58 | $6.64B | Diagnostic Equipment |
| 86 | CAICaris Life Sciences | 61.5% | 68.09 | $6.61B | Diagnostic Labs |
| 87 | LGNDLigand Pharmaceuticals | 1.0% | 119.78 | $6.18B | Biotechnology |
| 88 | FMSFresenius Medical Care AG | -49.1% | 6.71 | $6.16B | Healthcare Services |
| 89 | TFXTeleflex | 20.9% | 21.11 | $6.15B | Medical Devices |
| 90 | HAEHaemonetics | 4.1% | 53.80 | $5.59B | Medical Devices |
| 91 | CONConcentra Group Holdings Parent | 11.8% | 24.46 | $5.38B | Healthcare Services |
| 92 | MMSIMerit Medical Systems | 9.1% | 32.36 | $5.19B | Medical Devices |
| 93 | LIVNLivaNova | 11.7% | 25.66 | $5.03B | Medical Devices |
| 94 | EWTXEdgewise Therapeutics | 36.6% | 4.95 | $5.03B | Pharmaceuticals |
| 95 | BLLNBillionToOne | 71.9% | 108.18 | $5.01B | Diagnostic Labs |
| 96 | STVNStevanato Group S.p.A | 12.0% | 26.46 | $4.78B | Medical Supplies |
| 97 | SHCSotera Health | 6.9% | 27.38 | $4.74B | Diagnostic Labs |
| 98 | OPCHOption Care Health | 4.0% | 22.03 | $4.74B | Home Health and Senior Care |
| 99 | ICUIIcu Medical | -5.9% | 74.31 | $4.48B | Medical Devices |
| 100 | CRVLCorvel | 8.3% | 35.64 | $4.32B | Managed Care |
Among Healthcare stocks, the largest companies growing revenue faster than the median (10.1%) while trading below the median P/E (23.02) are Medtronic (MDT), Gsk (GSK), Regeneron Pharmaceuticals (REGN), Koninklijke Philips (PHG) and Alnylam Pharmaceuticals (ALNY). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.
The largest companies with a P/E above the median and revenue growth below it are Johnson & Johnson (JNJ), Unitedhealth (UNH), Merck (MRK), Astrazeneca (AZN) and Thermo Fisher Scientific (TMO).
The median P/E across the 219 Healthcare stocks plotted is 23.02, with the middle half between 11.30 and 40.09.
The median is 10.1%, with the middle half between 4.1% and 25.3%.
The rank correlation (Spearman) is 0.07, a no meaningful positive relationship: knowing one tells you little about the other.
A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 16 companies are outliers on Revenue Growth (1y) (TTM) and 9 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.
Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this sector is included unless you choose primary industry only. Nothing on this page is investment advice.